By Topic

De novo design of ligands /spl lsqb/automated drug design/spl rsqb/

Sign In

Cookies must be enabled to login.After enabling cookies , please use refresh or reload or ctrl+f5 on the browser for the login options.

Formats Non-Member Member
$33 $13
Learn how you can qualify for the best price for this item!
Become an IEEE Member or Subscribe to
IEEE Xplore for exclusive pricing!
close button

puzzle piece

IEEE membership options for an individual and IEEE Xplore subscriptions for an organization offer the most affordable access to essential journal articles, conference papers, standards, eBooks, and eLearning courses.

Learn more about:

IEEE membership

IEEE Xplore subscriptions

2 Author(s)
C. M. W. Ho ; Center for Molecular Design, Washington Univ., St. Louis, MO, USA ; G. R. Marshall

We have developed an integrated, rational drug-design system consisting of four programs: CAVITY, FOUNDATION, DBMAKER, and SPLICE. The first two programs are utilized to characterize the active site and retrieve complementary molecular fragments. Databases containing 3D structures for searching can be generated using the program DBMAKER along with CONCORD. Finally, the program SPLICE is used to edit and assemble recovered components into complete ligands. To illustrate the approach, novel ligands designed to complement the NADPH-binding site of DHFR were produced.<>

Published in:

System Sciences, 1994. Proceedings of the Twenty-Seventh Hawaii International Conference on  (Volume:5 )

Date of Conference:

4-7 Jan. 1994